Beta-adrenergic blocking drugs in breast cancer: a perspective review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta-adrenergic blocking drugs in breast cancer: a perspective review
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 4, Issue 3, Pages 113-125
Publisher
SAGE Publications
Online
2012-03-04
DOI
10.1177/1758834012439738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Can all beta blockers improve the breast cancer survival?
- (2011) Mehmet Ali Nahit Sendur et al. BREAST
- Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study
- (2011) D. G. Powe et al. BREAST CANCER RESEARCH AND TREATMENT
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
- (2011) Patricia A. Ganz et al. BREAST CANCER RESEARCH AND TREATMENT
- β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines
- (2011) Kelley S. Madden et al. BREAST CANCER RESEARCH AND TREATMENT
- Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
- (2011) Sunil M. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction
- (2011) Tao Shan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expanding Our Therapeutic Options: Beta Blockers for Breast Cancer?
- (2011) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergism between immunostimulation and prevention of surgery-induced immune suppression: An approach to reduce post-operative tumor progression
- (2010) Roi Avraham et al. BRAIN BEHAVIOR AND IMMUNITY
- The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
- (2010) Ming Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
- (2010) C.H. Storch et al. BRITISH JOURNAL OF DERMATOLOGY
- β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF-κB and AP-1
- (2010) Dong Zhang et al. CANCER BIOLOGY & THERAPY
- The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
- (2010) E. K. Sloan et al. CANCER RESEARCH
- 445 Beta-blocker treatment is associated with a reduction in tumour metastasis and an improvement in specific survival in patients with breast cancer
- (2010) D.G. Powe et al. EJC SUPPLEMENTS
- Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas
- (2010) Clemens Schiestl et al. EUROPEAN JOURNAL OF PEDIATRICS
- Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism
- (2010) Soon Young Park et al. INTERNATIONAL JOURNAL OF CANCER
- Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
- (2010) Anil K. Sood et al. JOURNAL OF CLINICAL INVESTIGATION
- Host Factors and Cancer Outcome
- (2010) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions
- (2010) Susan K. Lutgendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor
- (2010) Ariella Glasner et al. JOURNAL OF IMMUNOLOGY
- β-Adrenergic Receptors in Cancer: Therapeutic Implications
- (2010) Mario Pérez-Sayáns et al. ONCOLOGY RESEARCH
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
- (2009) Sonja Loges et al. CANCER CELL
- Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma
- (2009) J.-W. Lee et al. CLINICAL CANCER RESEARCH
- Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis
- (2008) Marganit Benish et al. ANNALS OF SURGICAL ONCOLOGY
- Neuroendocrine modulation of cancer progression
- (2008) Guillermo N. Armaiz-Pena et al. BRAIN BEHAVIOR AND IMMUNITY
- Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression
- (2008) Eric V. Yang et al. BRAIN BEHAVIOR AND IMMUNITY
- Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via β-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway
- (2008) Xuan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction
- (2008) Dong Zhang et al. PANCREAS
- Do stress-related psychosocial factors contribute to cancer incidence and survival?
- (2008) Yoichi Chida et al. Nature clinical practice. Oncology
- VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine
- (2007) Eric V. Yang et al. BRAIN BEHAVIOR AND IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started